ORMP

#3822
Oramed Pharmaceuticals Inc.
3.78 USD
-0.53%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
3.78
3.81
Rango anual
1.98
3.91
Cambio diario
-0.53%
Variación mensual
+10.85%
Variación en los últimos 6 meses
+65.79%
Cambio anual
+71.04%
Cierres anteriores
3.80
Abrir
3.81
Bid
Ask
Mínimo
3.78
High
3.81
Volumen
8
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Noticias